Filed with ASX · · 3 pages · English
Nyrada, Inc. has announced the quotation of Attaching Options on the ASX, which were issued under its recent capital raise. These options will commence trading under the ticker NYRO and are exercisable at a specified price until a future date. The filing also mentions that director participation in the capital raise is subject to shareholder approval at an upcoming extraordinary general meeting.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
5 November 2026 Sydney, Australia Quotation of Attaching Options Nyrada Inc. (ASX:NYR), a clinical-stage biotechnology company focused on developing Transient Receptor Potential Canonical (TRPC) ion channel inhibitors to treat a range of medical conditions, advises that the Attaching Options issued...
Follow Nyrada into a list and get an email when it puts out news.
Follow Nyrada